Co-administration of equimolar doses of betaine may alleviate the hepatotoxic risk associated with niacin therapy
Open Access
- 1 September 2000
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 55 (3) , 189-194
- https://doi.org/10.1054/mehy.1999.1011
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Treatment of hyperlipidemia with combined niacin–statin regimensThe American Journal of Cardiology, 1998
- Effects of Crystalline Nicotinic Acid-Induced Hepatic Dysfunction on Serum Low-Density Lipoprotein Cholesterol and Lecithin Cholesteryl Acyl TransferaseThe American Journal of Cardiology, 1998
- New developments in the use of niacin for treatment of hyperlipidemiaCoronary Artery Disease, 1996
- A Population Based Strategy to Prevent Insulin-Dependent Diabetes Using NicotinamideJournal of Pediatric Endocrinology and Metabolism, 1996
- Creatine in Humans with Special Reference to Creatine SupplementationSports Medicine, 1994
- Effect of S-adenosyl-L-methionine on brain muscarinic receptors of aged ratsEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Effect of nicotinic acid-induced insulin resistance on pancreatic B cell function in normal and streptozocin-treated baboons.Journal of Clinical Investigation, 1991
- Nicotinamide methylation and its relation to NAD synthesis in rat liver tissue cultureBiochemical basis fro the physiological activities of 1-methylnicotinamideBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Betaine, metabolic by-product or vital methylating agent?Life Sciences, 1983
- Metabolic Effects and Liver Damage after Prolonged Administration of High Doses of Nicotinamide to RatsAnnals of Nutrition and Metabolism, 1977